| DELCATH SYS NEW DL-,01 |
| USA |
| Gesundheit |
| US24661P8077 / A2PT5P |
| DV3R (Frankfurt) / DCTH (NASDAQ) |
| FRA:DV3R, ETR:DV3R, DV3R:GR, NASDAQ:DCTH |
| - |
| http://delcath.com/ |
|
Delcath Systems Inc. is a medical device company focused on providing treatment options for primary and metastatic liver cancers through its innovative technologies. Central to their product offerings is the percutaneous hepatic perfusion (PHP) syste..
>Volltext.. |
| 390.39 Mio. EUR |
| 314.03 Mio. EUR |
| 78.43 Mio. EUR |
| -1.05 Mio. EUR |
| 0.49 Mio. EUR |
| 0.01 EUR |
| 0.79 Mio. EUR |
| 35.83 Mio. EUR |
| 18.36 Mio. EUR |
| 8.35 |
| 57.26% |
| - |
| - |
| - |
| - |
| - |
| DELCATH |
| 06.08.26 |
|
||||
|
||||
|
||||
|
||||
|